Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial
R. D'Cruz (London, United Kingdom), A. Rossel (London, United Kingdom), E. Suh (London, United Kingdom), G. Kaltsakas (London, United Kingdom), N. Shah (London, United Kingdom), A. Dewar (London, United Kingdom), L. Rose (London, United Kingdom), P. Murphy (London, United Kingdom), N. Hart (London, United Kingdom)
Source: Virtual Congress 2021 – New trends in non-invasive respiratory support
Session: New trends in non-invasive respiratory support
Session type: Oral Presentation
Number: 1626
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. D'Cruz (London, United Kingdom), A. Rossel (London, United Kingdom), E. Suh (London, United Kingdom), G. Kaltsakas (London, United Kingdom), N. Shah (London, United Kingdom), A. Dewar (London, United Kingdom), L. Rose (London, United Kingdom), P. Murphy (London, United Kingdom), N. Hart (London, United Kingdom). Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial. 1626
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017
Nasal high-flow oxygen versus noninvasive ventilation in acute exacerbation of COPD: protocol for a randomised noninferiority clinical trial Source: ERJ Open Res, 6 (4) 00114-2020; 10.1183/23120541.00114-2020 Year: 2020
Effectiveness of a pharmacist-led inhalation technique intervention on asthma and COPD patients: The INspira cluster-randomized controlled trial Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021
Domiciliary high-flow nasal cannula oxygen therapy for stable hypercapnic chronic obstructive pulmonary disease: a prospective, multicentre, randomised crossover trial Source: International Congress 2017 – New insights in chronic respiratory failure Year: 2017
Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019 Year: 2020
Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX) Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment Year: 2018
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019 Year: 2019
Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial> Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019
Outpatient vs. home-based pulmonary rehabilitation in COPD: A randomized controlled trial Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011
A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019 Year: 2019
Home-based pulmonary rehabilitation in patients with bronchiectasis: a randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017
Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial Source: ERJ Open Res, 7 (3) 00738-2020; 10.1183/23120541.00738-2020 Year: 2021
High flow nasal cannula during walking in severe COPD patients: a randomized controlled trial. Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018
Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013
Efficacy of an integrated internet community program after pulmonary rehabilitation for COPD patients: a pilot randomized control trial Source: International Congress 2017 – The importance of physical activity in patients with COPD Year: 2017
Efficacy and safety of isoproterenol continuous inhalation treatment for acute severe exacerbation of asthma in children; a randomized, double-blind controlled study Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015
Web-based self-management support after pulmonary rehabilitation of difficult to treat asthma: a randomised controlled trial Source: International Congress 2017 – Techniques to treat asthma Year: 2017
Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation Source: Eur Respir J 2014; 43: 717-724 Year: 2014